Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Synchron Inc. is at the forefront of neurotechnology, developing groundbreaking implantable brain-computer interfaces (BCIs) designed to help individuals with severe paralysis regain communication and functional independence. Their flagship product, the Stentrode™, is an endovascular BCI implanted via blood vessels, avoiding open brain surgery. Synchron aims to translate brain signals into actions, enabling control of digital devices and improving quality of life for patients with conditions like ALS, stroke, and spinal cord injury. They are a clinical-stage company actively conducting trials and pushing the boundaries of neural interface technology.
Serves as the central hub for global operations, strategic decision-making, corporate functions, and coordination of research and development efforts across its international sites.
Located within the historic and revitalized Brooklyn Navy Yard, known for fostering innovation and technology. The HQ likely features modern office spaces. In July 2023, Synchron announced a new 15,000 sq ft R&D and manufacturing facility at the Brooklyn Navy Yard.
As a pioneering neurotechnology company, the work culture at Synchron's HQ is dynamic, collaborative, and mission-driven, attracting talent passionate about solving complex medical challenges. Emphasis on innovation, scientific rigor, and patient impact.
The Brooklyn HQ positions Synchron within a major biotech and innovation hub, facilitating access to talent, research institutions, and a vibrant tech community. It underscores their commitment to US-based leadership in the BCI field.
Synchron Inc. supports its global mission through key operational and R&D hubs in the United States (New York and California) and Australia (Melbourne). These locations facilitate research, development, clinical trials, manufacturing oversight, and strategic partnerships across multiple continents, enabling the company to advance its neurovascular BCI technology and prepare for future commercialization worldwide.
Brooklyn Navy Yard
Brooklyn
NY
USA
Address: 1999 S Bascom Ave, Ste 700, Campbell, California, 95008, United States
To tap into the specialized engineering, software development, and medical device expertise prevalent in the San Francisco Bay Area and Silicon Valley, accelerating product development and clinical research.
Address: Located in the vicinity of Melbourne's biomedical precinct, building on its foundational research origins.
To continue collaboration with leading Australian research institutions and clinicians, drive early-stage innovation, and support clinical trials in the Asia-Pacific region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Synchron' leadership includes:
Synchron has been backed by several prominent investors over the years, including:
Over the past year (May 2023 - May 2024), Synchron Inc. has significantly strengthened its executive team with key strategic hires across finance, technology, legal, R&D, and commercial operations, positioning the company for its next phase of growth and clinical advancement. No high-profile executive exits have been publicly announced during this period.
Discover the tools Synchron uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Synchron Inc. primarily utilizes an email format combining the employee's first initial followed by their last name (e.g., jdoe@synchron.com). This is a common structure for technology and life sciences companies.
f[last]@synchron.com
Format
toxley@synchron.com
Example
85%
Success rate
Synchron Press Release • March 20, 2024
Synchron announced the appointment of Andy Hnowski as Chief Commercial Officer. Hnowski will be responsible for developing and executing Synchron's commercialization strategy as the company advances its Brain-Computer Interface (BCI) technology towards market....more
Synchron Press Release • February 28, 2024
Synchron has appointed Will Cook as its new Vice President of Research & Development. Cook will lead the R&D team in advancing Synchron's innovative neurotechnology platform, including the Stentrode™....more
Synchron Press Release • July 26, 2023
Synchron announced the opening of a new 15,000 square foot R&D and manufacturing facility at the Brooklyn Navy Yard. This expansion aims to scale up the production of its brain-computer interface (BCI) technology and support ongoing clinical trials....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Synchron, are just a search away.